Get started
LGALS3

Cross above 200 day moving average, cup and handle

Long
Galectin Therapeutics Inc. (BATS:GALT)  
LGALS3  
BATS:GALT   Galectin Therapeutics Inc.
Moving Averages Fundamental Analysis Growth
0
0
movingaverage fundamental growth
GALT cross above 200 day moving average after a lengthy period of consolidation in tightening trading range.

Cup and handle.

Leading drug in a pivotal clinical trial for advanced cirrhosis.

  • High insider ownership of shares
  • Recent hiring of a renowned liver expert VP from big pharma
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.